Pre-IPO OrbusNeich Medical Group - The Industry, the Business and the Concerns
The rich pipeline and large global business will help OrbusNeich “hedge” negative domestic policy impact. But fierce competition, slow progress in...
673 Views
Shanghai Bio-Heart IPO: Strong Product Candidates but For Those Willing to Wait
If approved, Bio-heart’s products will have strong potential but we would like to highlight that these still in development stage and the company...
289 Views
Pre-IPO Shanghai Bio-Heart Biological Technology - Conservative About the Outlook
The insight mainly analyzed Bio-heart Biological Technology in terms of the industry characteristics, the policy impact, the business of core...
334 Views
Shanghai HeartCare (心玮医疗) Pre-IPO: Thoughts on Valuation
We forecast the sales of HeartCare's four key products, namely Captor, Intracranial Catheter, LAA Occluder, and embolic coil, and also provide an...
638 Views
Shanghai Bio-Heart (上海百心安) Pre-IPO: Thoughts on Valuation
We provide a pre-money based valuation for Shanghai Bio-heart listing. We forecast the sales for its BRS and RDN respectively. We would re-iterate...
444 Views